https://www.selleckchem.com/TGF-beta.html
71, p=0.0079) and disease progression (HR2.71, p=0.0024) with the effect being potentiated by the co-occurrence of T/T genotype of rs2853669. -124 CT promoter mutation as well as the T/T genotype of the rs2853669 SNP are attractive independent prognostic biomarkers in patients surgically treated for OCSCC, with the coexistence of these genetic variants showing a synergistic impact on the aggressiveness of the disease. T TERT promoter mutation as well as the T/T genotype of the rs2853669 SNP are attractive independent prognostic biomarkers i